{
  "thread": {
    "uuid": "8632abde60314f569cc85416a4f33ebef1059d6a",
    "url": "https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "site_full": "www.marketbeat.com",
    "site": "marketbeat.com",
    "site_section": "https://www.marketbeat.com/rss.ashx?type=headlines",
    "site_categories": [
      "investing",
      "financial_news",
      "finance",
      "stocks"
    ],
    "section_title": "MarketBeat News Feed",
    "site_title": "MarketBeat: Stock Market News and Research Tools",
    "title": "Insider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 1,032,218 Shares of Stock",
    "title_full": "Insider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 1,032,218 Shares of Stock",
    "published": "2025-04-17T00:55:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://www.marketbeat.com/logos/prokidney-corp-logo-1200x675.png?v=20240520152354",
    "performance_score": 0,
    "domain_rank": 7938,
    "domain_rank_updated": "2025-04-15T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "8632abde60314f569cc85416a4f33ebef1059d6a",
  "url": "https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
  "ord_in_thread": 0,
  "author": "MarketBeat",
  "published": "2025-04-17T00:55:00.000+03:00",
  "title": "Insider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 1,032,218 Shares of Stock",
  "text": "Insider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 1,032,218 Shares of Stock Written by MarketBeat April 16, 2025 Share Link copied to clipboard. Remove Ads ProKidney Corp. ( NASDAQ:PROK - Get Free Report ) insider Control Empresarial De Capital bought 1,032,218 shares of the stock in a transaction that occurred on Thursday, April 10th. The stock was purchased at an average price of $0.61 per share, for a total transaction of $629,652.98. Following the completion of the purchase, the insider now directly owns 72,592,325 shares in the company, valued at $44,281,318.25. The trade was a 1.44 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link . Get ProKidney alerts: Sign Up ProKidney Trading Up 1.2 %\nNASDAQ:PROK traded up $0.01 during trading hours on Monday, hitting $0.74. 728,250 shares of the company traded hands, compared to its average volume of 690,149. ProKidney Corp. has a twelve month low of $0.46 and a twelve month high of $4.44. The firm has a 50-day moving average of $1.10 and a 200 day moving average of $1.54. The stock has a market capitalization of $216.60 million, a price-to-earnings ratio of -1.35 and a beta of 1.52.\nProKidney ( NASDAQ:PROK - Get Free Report ) last announced its quarterly earnings data on Monday, March 17th. The company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.03). The firm had revenue of $0.08 million for the quarter. Equities research analysts predict that ProKidney Corp. will post -0.57 earnings per share for the current fiscal year. Institutional Trading of ProKidney\nA number of institutional investors and hedge funds have recently modified their holdings of PROK. Geode Capital Management LLC boosted its stake in ProKidney by 102.0% during the third quarter. Geode Capital Management LLC now owns 2,203,934 shares of the company's stock worth $4,232,000 after buying an additional 1,112,933 shares in the last quarter. Hennion & Walsh Asset Management Inc. bought a new position in shares of ProKidney during the 4th quarter worth about $961,000. Charles Schwab Investment Management Inc. boosted its position in shares of ProKidney by 150.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 749,718 shares of the company's stock valued at $1,439,000 after acquiring an additional 450,548 shares in the last quarter. State Street Corp raised its position in ProKidney by 16.2% in the third quarter. State Street Corp now owns 1,428,318 shares of the company's stock worth $2,742,000 after purchasing an additional 198,836 shares in the last quarter. Finally, Bleichroeder LP lifted its stake in ProKidney by 8.4% during the fourth quarter. Bleichroeder LP now owns 2,000,000 shares of the company's stock worth $3,380,000 after purchasing an additional 155,000 shares during the period. 51.59% of the stock is currently owned by institutional investors. ProKidney Company Profile ( Get Free Report )\nProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. See Also\nRemove Ads This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.\nShould You Invest $1,000 in ProKidney Right Now? Before you consider ProKidney, you'll want to hear this.\nMarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProKidney wasn't on the list.\nWhile ProKidney currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.\nView The Five Stocks Here\nThese 7 Stocks Will Be Magnificent in 2025 Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.\nGet This Free Report Like this article? Share it with a colleague. Link copied to clipboard.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Economy, Business and Finance",
    "Politics",
    "Human Interest"
  ],
  "topics": [
    "Economy, Business and Finance->financial service",
    "Politics->regulation of industry",
    "Politics->economic policy"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20%24PROK%20%23PROK%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://www.facebook.com/sharer/sharer.php?u=https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "http://www.sec.gov/Archives/edgar/data/1273693/000114036125013770/xslF345X05/form4.xml",
    "https://www.americanconsumernews.net/scripts/standalone/viewcount.ashx?type=i&id=662137&domain=marketbeat.com&referrer=",
    "https://www.american",
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://www.facebook.com/sharer/sharer.php?u=https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20%24PROK%20%23PROK%20https://marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://facebook.com/sharer/sharer.php?u=https://marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "http://sec.gov/Archives/edgar/data/1273693/000114036125013770/xslF345X05/form4.xml",
    "https://linkedin.com/cws/share?mini=true&url=https://marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14/",
    "https://american",
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "https://twitter.com/intent/tweet?text=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20%24PROK%20%23PROK%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "https://www.facebook.com/sharer/sharer.php",
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Insider+Buying%3a+ProKidney+Corp.+(NASDAQ%3aPROK)+Insider+Purchases+1%2c032%2c218+Shares+of+Stock%20https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "https://www.linkedin.com/cws/share",
    "https://www.americanconsumernews.net/scripts/standalone/viewcount.ashx",
    "https://api.stocktwits.com/widgets/share",
    "https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/instant-alerts/insider-buying-prokidney-corp-nasdaqprok-insider-purchases-1032218-shares-of-stock-2025-04-14",
    "https://americanconsumernews.net/scripts/standalone/viewcount.ashx?type=i&id=662137&domain=marketbeat.com&referrer=",
    "https://twitter.com/intent/tweet"
  ],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": [
      {
        "name": "ProKidney Corp.",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "Securities & Exchange Commission",
        "sentiment": "none",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-04-17T01:10:02.618+03:00",
  "updated": "2025-04-17T01:10:02.618+03:00"
}